Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Farmers Insurance
Johnson and Johnson
Merck
Colorcon
Healthtrust
UBS
Federal Trade Commission

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,722,037

« Back to Dashboard

Which drugs does patent 8,722,037 protect, and when does it expire?

Patent 8,722,037 protects NEXPLANON and is included in one NDA.

This patent has thirty-two patent family members in thirty-one countries.
Summary for Patent: 8,722,037
Title:X-ray visible drug delivery device
Abstract: The subject invention provides an X-ray visible drug delivery device for subdermal administration of a contraceptive or hormone replacement therapy.
Inventor(s): Veenstra; Harm (Oss, NL), De Graaff; Wouter (Oss, NL)
Assignee: Meck Sharp & Dohme B.V. (BN Harleem, NL)
Application Number:10/592,725
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;

Drugs Protected by US Patent 8,722,037

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,722,037

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
04101151Mar 19, 2004
PCT Information
PCT FiledMarch 14, 2005PCT Application Number:PCT/EP2005/051150
PCT Publication Date:September 29, 2005PCT Publication Number: WO2005/089814

International Family Members for US Patent 8,722,037

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 048106 ➤ Try a Free Trial
Austria 399569 ➤ Try a Free Trial
Australia 2005224054 ➤ Try a Free Trial
Brazil PI0508865 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Chinese Patent Office
Johnson and Johnson
Medtronic
Queensland Health
UBS
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.